Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism Modulates Reversible Cerebral Vasoconstriction Syndromes
2011

BDNF Gene Variant and Reversible Cerebral Vasoconstriction

Sample size: 270 publication Evidence: moderate

Author Information

Author(s): Chen Shih-Pin, Fuh Jong-Ling, Wang Shuu-Jiun, Tsai Shih-Jen, Hong Chen-Jee, Yang Albert C.

Primary Institution: Taipei Veterans General Hospital

Hypothesis

The BDNF Val66Met polymorphism might have modulatory effects on RCVS, especially vasoconstriction.

Conclusion

The study found that the BDNF Val66Met polymorphism is linked to the severity of RCVS for the first time.

Supporting Evidence

  • Patients with Val allele had higher mean vasoconstriction scores than those with Met/Met homozygosity.
  • 38.9% of Val carriers had VMCA values of >120 cm/s, compared to none of the Met/Met homozygotes.
  • The study used a split-sample approach to validate findings.

Takeaway

This study looked at how a specific gene might affect a condition that causes severe headaches and blood vessel problems in the brain.

Methodology

Patients with RCVS and controls were genotyped for the BDNF Val66Met polymorphism, and various imaging techniques were used to evaluate cerebral vasoconstriction.

Potential Biases

The study did not check plasma BDNF levels, which could affect the results.

Limitations

The sample size was not large enough for a genetic polymorphism study, which might have led to false negative results.

Participant Demographics

90 Taiwanese patients with RCVS and 180 age- and gender-matched controls.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1371/journal.pone.0018024

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication